Farallon Capital Management 13F holdings, Q4 2019
Holdings as of December 31, 2019 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 112 US equity positions worth $13.0bn in its Q4 2019 13F filing. The largest position was ALLERGAN PLC at 11.8% of the reported book, followed by WELLCARE HEALTH PLANS INC and IAC INTERACTIVECORP. Against the Q3 2019 filing, it opened 10 new positions, added to 22 and reduced 15 among the top 50 holdings.
What did Farallon Capital Management own in Q4 2019? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2019 |
|---|---|---|---|---|---|---|---|
| 1 | ALLERGAN PLC | 11.8% | $1.5bn | 7,990,000 | 28% | added | |
| 2 | WELLCARE HEALTH PLANS INC | 6.1% | $792.5m | 2,400,000 | 1% | added | |
| 3 | IAC INTERACTIVECORP | 4.0% | $514.8m | 2,066,500 | 42% | added | |
| 4 | FIS FIDELITY NATL INFORMATION SV | Technology | 3.7% | $484.8m | 3,485,757 | 14% | added |
| 5 | WAB WABTEC CORP | Industrials | 3.0% | $394.4m | 5,069,187 | -19% | reduced |
| 6 | ELV ANTHEM INC | Healthcare | 2.9% | $377.5m | 1,250,000 | 18% | added |
| 7 | GOOG ALPHABET INC | Communication Services | 2.8% | $367.6m | 274,903 | 10% | added |
| 8 | MSFT MICROSOFT CORP | Technology | 2.7% | $344.7m | 2,185,790 | 55% | added |
| 9 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 2.6% | $331.4m | 683,093 | -3% | reduced |
| 10 | CI CIGNA CORP NEW | Healthcare | 2.4% | $306.7m | 1,500,000 | 41% | added |
| 11 | IQV IQVIA HLDGS INC | Healthcare | 2.2% | $286.6m | 1,854,687 | -30% | reduced |
| 12 | V VISA INC | Financial Services | 2.2% | $286.1m | 1,522,460 | 18% | added |
| 13 | MEDICINES CO | 2.2% | $281.6m | 3,315,000 | – | new | |
| 14 | CRM SALESFORCE COM INC | Technology | 2.2% | $280.5m | 1,724,880 | – | new |
| 15 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 2.1% | $277.2m | 853,160 | – | new |
| 16 | PLAYA HOTELS & RESORTS NV | 2.0% | $257.1m | 30,606,930 | 0% | held | |
| 17 | PANW PALO ALTO NETWORKS INC | Technology | 2.0% | $256.3m | 1,108,416 | 82% | added |
| 18 | EQIX EQUINIX INC | Real Estate | 1.9% | $243.0m | 416,323 | 12% | added |
| 19 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 1.9% | $240.2m | 1,132,500 | -48% | reduced |
| 20 | ZAYO GROUP HLDGS INC | 1.8% | $236.3m | 6,820,000 | 38% | added | |
| 21 | ABBV ABBVIE INC | Healthcare | 1.7% | $221.3m | 2,500,000 | 150% | added |
| 22 | SHW SHERWIN WILLIAMS CO | Basic Materials | 1.7% | $214.6m | 367,775 | -18% | reduced |
| 23 | META FACEBOOK INC | Communication Services | 1.6% | $211.5m | 1,030,313 | -24% | reduced |
| 24 | IHS MARKIT LTD | 1.6% | $206.7m | 2,743,550 | -23% | reduced | |
| 25 | ASND ASCENDIS PHARMA A S | Healthcare | 1.4% | $177.9m | 1,279,000 | -17% | reduced |
| 26 | SPGI S&P GLOBAL INC | Financial Services | 1.3% | $174.9m | 640,382 | -23% | reduced |
| 27 | GD GENERAL DYNAMICS CORP | Industrials | 1.3% | $173.1m | 981,365 | -1% | reduced |
| 28 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1.3% | $173.0m | 6,250,000 | 4% | added |
| 29 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.3% | $167.0m | 1,450,000 | -3% | reduced |
| 30 | MYOKARDIA INC | 1.2% | $149.4m | 2,050,000 | 1% | added | |
| 31 | EXEL EXELIXIS INC | Healthcare | 1.0% | $132.2m | 7,500,000 | 329% | added |
| 32 | TRU TRANSUNION | Financial Services | 1.0% | $130.8m | 1,527,771 | 22% | added |
| 33 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.8% | $108.1m | 1,750,000 | 37% | added |
| 34 | XLRN ACCELERON PHARMA INC | 0.8% | $106.0m | 2,000,000 | -17% | reduced | |
| 35 | BROADMARK RLTY CAP INC | 0.7% | $91.5m | 7,174,613 | – | new | |
| 36 | BRISTOL MYERS SQUIBB CO | 0.7% | $91.4m | 30,374,950 | – | new | |
| 37 | EFX EQUIFAX INC | Industrials | 0.7% | $91.4m | 652,189 | 3% | added |
| 38 | ZOGENIX INC | 0.7% | $91.2m | 1,750,000 | 0% | held | |
| 39 | AMARIN CORP PLC | 0.7% | $88.4m | 4,125,000 | 106% | added | |
| 40 | ANIXTER INTL INC | 0.7% | $84.5m | 917,893 | – | new | |
| 41 | ZYME ZYMEWORKS INC | Healthcare | 0.6% | $77.3m | 1,700,000 | -2% | reduced |
| 42 | QGEN QIAGEN NV | Healthcare | 0.6% | $72.8m | 2,154,000 | – | new |
| 43 | GRFS GRIFOLS S A | Healthcare | 0.6% | $72.5m | 3,113,222 | 0% | held |
| 44 | AUDENTES THERAPEUTICS INC | 0.5% | $71.2m | 1,190,000 | – | new | |
| 45 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.5% | $59.7m | 1,250,000 | – | new |
| 46 | GLOBAL BLOOD THERAPEUTICS IN | 0.5% | $59.6m | 750,000 | -53% | reduced | |
| 47 | CHEMOCENTRYX INC | 0.5% | $59.3m | 1,500,000 | -25% | reduced | |
| 48 | DECIPHERA PHARMACEUTICALS IN | 0.5% | $59.1m | 950,000 | 27% | added | |
| 49 | FIBROGEN INC | 0.4% | $57.9m | 1,350,000 | 35% | added | |
| 50 | RA PHARMACEUTICALS INC | 0.4% | $55.8m | 1,188,100 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.